Cargando…

Sclerostin Concentration and Bone Biomarker Trends in Patients with Spinal Cord Injury: A Prospective Study

Patients with spinal cord injury (SCI) experience a high osteoporosis incidence, which increases fracture risk. Recently, a sclerostin antibody was introduced as a target biomarker to treat osteoporosis. We aimed to determine the serum concentration of sclerostin and factors affecting its concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Jong Ho, Cho, Jang Hyuk, Lee, Dong Gyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222769/ https://www.ncbi.nlm.nih.gov/pubmed/35742035 http://dx.doi.org/10.3390/healthcare10060983

Ejemplares similares

Natural History of Isolated Below-Knee Vein Thrombosis in Patients with Spinal Cord Injury
por: Cho, Jang-Hyuk, et al.
Publicado: (2021)

Correlation Between D-Dimer Level and Deep Venous Thrombosis in Patients With Acute Spinal Cord Injuries
por: Cho, Jang Hyuk, et al.
Publicado: (2020)

Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury
por: Phillips, Ean G., et al.
Publicado: (2018)

Trabecular bone score and sclerostin concentrations in patients with primary adrenal insufficiency
por: Zdrojowy-Wełna, Aleksandra, et al.
Publicado: (2022)

Influence of Muscle Mass and Strength on Bone Mineralisation with Consideration of Sclerostin Concentration
por: Patalong-Wójcik, Martyna, et al.
Publicado: (2023)

The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022)

Injury of the Papez circuit in a patient with traumatic spinal cord injury and concomitant mild traumatic brain injury
por: Jang, Sung Ho, et al.
Publicado: (2018)

Sclerostin: From Molecule to Clinical Biomarker
por: Omran, Ahmed, et al.
Publicado: (2022)

The Role of Sclerostin in Bone and Ectopic Calcification
por: De Maré, Annelies, et al.
Publicado: (2020)

Effects of sclerostin antibody on bone healing
por: Mihara, Atsushi, et al.
Publicado: (2021)

Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma
por: Gerov, Vladimir, et al.
Publicado: (2023)

IL-1β contributes to the secretion of sclerostin by osteocytes and targeting sclerostin promotes spinal fusion at early stages
por: Jiang, Zengxin, et al.
Publicado: (2023)

Spinal Cord Injury Fact Sheet in Korea
por: KIM, Han-Kyoul, et al.
Publicado: (2023)

Sclerostin
por: Silverman, Stuart L.
Publicado: (2010)

Elevated Circulating Sclerostin Concentrations in Individuals With High Bone Mass, With and Without LRP5 Mutations
por: Gregson, Celia L., et al.
Publicado: (2014)

Sclerostin expression in trabecular bone is downregulated by osteoclasts
por: Koide, Masanori, et al.
Publicado: (2020)

Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
por: Wang, Jialiang S., et al.
Publicado: (2021)

Obesity and Bone Loss at Menopause: The Role of Sclerostin
por: Marzullo, Paolo, et al.
Publicado: (2021)

Importance of Sclerostin as Bone-Muscle Mediator Crosstalk
por: Aryana, I Gusti Putu Suka, et al.
Publicado: (2022)

Sclerostin: clinical insights in muscle–bone crosstalk
por: Moretti, Antimo, et al.
Publicado: (2023)

Factors Affecting Quality of Life Among Spinal Cord Injury Patients in Korea
por: Lee, Jong Soo, et al.
Publicado: (2016)

Interdisciplinary Approaches to Spinal Cord Injuries: Innovations, Collaborations, and the Role of the Korean Spinal Cord Society and Korean Neurotraumatology Society
por: Oh, Hyuk Jin, et al.
Publicado: (2023)

Spinal Cord Injury in Myelomeningocele: Prospects for Therapy
por: Janik, Karolina, et al.
Publicado: (2020)

Direct effects of physical training on markers of bone metabolism and serum sclerostin concentrations in older adults with low bone mass
por: Gombos, Gabriella Császárné, et al.
Publicado: (2016)

Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
por: van Dinther, Maarten, et al.
Publicado: (2013)

Biomarkers for Severity of Spinal Cord Injury in the Cerebrospinal Fluid of Rats
por: Lubieniecka, Joanna M., et al.
Publicado: (2011)

Sclerostin as a novel marker of bone turnover in athletes
por: Zagrodna, A, et al.
Publicado: (2016)

Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement
por: Shu, Rui, et al.
Publicado: (2017)

Sclerostin expression in the subchondral bone of patients with knee osteoarthritis
por: Wu, Long, et al.
Publicado: (2016)

Sclerostin's role in bone's adaptive response to mechanical loading
por: Galea, Gabriel L, et al.
Publicado: (2017)

Anti-Sclerostin Antibodies in Osteoporosis and Other Bone Diseases
por: Fabre, Stéphanie, et al.
Publicado: (2020)

Sclerostin Depletion Induces Inflammation in the Bone Marrow of Mice
por: Donham, Cristine, et al.
Publicado: (2021)

The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
por: Zhou, Bing-na, et al.
Publicado: (2022)

Osteocytic Sclerostin Expression as an Indicator of Altered Bone Turnover
por: Huybrechts, Yentl, et al.
Publicado: (2023)

FGF-23 and sclerostin in serum and bone of CKD patients
por: Lima, Florence, et al.
Publicado: (2023)

In vivo imaging in experimental spinal cord injury – Techniques and trends
por: Hubertus, Vanessa, et al.
Publicado: (2021)

Long-Term Efficacy of Mirabegron Add-On Therapy to Antimuscarinic Agents in Patients With Spinal Cord Injury
por: Han, Seok-Hee, et al.
Publicado: (2019)

Spinal Cord Infarction After Transarterial Chemoembolization for Hepatocellular Carcinoma
por: Lee, Sang-Geun, et al.
Publicado: (2022)

Bone morphogenic protein signaling in spinal cord injury
por: Al-Sammarraie, Nadia, et al.
Publicado: (2021)

Assessment of the Concentration of Bone Metabolism Markers: Sclerostin and FGF-23 in Children with Idiopathic Nephrotic Syndrome Treated with Glucocorticosteroids
por: Pukajło-Marczyk, Agnieszka, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2qskf8hav6et32dqe9suu4kv8f